Invitae Corporation IPO Research Information

Invitae Corporation IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Invitae Corporation, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Invitae Corporation	NVTA - NYSE	$13.00-$15.00	$16.00	$17.50	6.35 million	2/12/2015
Underwriter(s): J.P. Morgan
Co-Manager(s): Cowen and Company, Leerink Partners
Industry: Health Care
Filing(s): Filed 2015-01-09 Terms Added 2015-02-02

Invitae Corporation Quote & Chart - Click for current quote - NVTA

About Invitae Corporation (adapted from Invitae Corporation prospectus):
Invitae's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "NVTA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.